Agomelatine in Depressed Patients With Fibromyalgia

• Status: Completed
• Trial end date: 2012-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Depression and unrefreshed sleep are frequent in patients with fibromyalgia. Agomelatine is a new antidepressant with sleep-promoting properties. The objective of this study include the assessment of agomelatine therapy in patients with depression and fibromyalgia both on the severity of depressive symptomatology and sleep quality.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universidad de Granada
• Treatments: S 20098

Criteria

Inclusion Criteria:

• adult patients

• diagnosed of fibromyalgia according to the American College of Rheumatology criteria

• diagnosed of major depression according to the DSM-IV criteria with a BDI-II score equal or higher tahn 20

Exclusion Criteria:

• other psychiastric concomitant illness

• pregnancy or lactation

• patients previously treated with agomelatine with little or no effect